Immix Biopharma, Inc

About Immix Biopharma, Inc

Immix Biopharma, Inc. is a privately held, biopharmaceutical firm focused on developing safe and effective therapies for cancer patients. The team was founded by Vladimir Torchilin, Ph.D., D.Sc. Director of the Center for Pharmaceutical Biotechnology and Nanomedicine at Northeastern University and the former Head of Chemistry Program at Harvard Medical School and Massachusetts General Hospital; Ilya Rachman, an MD, PhD, MBA, physician scientist and clinical researcher; and Sean D. Senn, JD, MSc., MBA, a senior biotechnology patent attorney and fund manager.

YEAR FOUNDED:
2012
LEADERSHIP:
Founders: Ilya Rachman, Sean Senn, and Vladimir Torchilin
CEO: Ilya Rachman
CLINICAL TRIAL:
Please click here for clinical trial information.